Related Experiment Video

Updated: Aug 9, 2025

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo
05:16

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo

Published on: July 25, 2025

152

A tour de force provides novel insights into CD19-CAR T cell resistance mechanisms

Aimee C Talleur1, Stephen Gottschalk1

  • 1Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA.

Cell Reports. Medicine
|February 22, 2023
PubMed

Insights

Researchers developed a new method to understand why some large B-cell lymphoma patients resist CD19-CAR T-cell therapy. This approach offers insights into resistance mechanisms and future treatment strategies.

Area of Science:

  • Immunotherapy
  • Oncology
  • Molecular Biology

Background:

  • CD19-CAR T-cell therapy shows promise for large B-cell lymphomas.
  • Understanding resistance mechanisms is crucial for improving treatment efficacy.

Purpose of the Study:

  • To develop and apply an integrated approach for simultaneous profiling of tumors and effector cells.
  • To investigate the mechanisms of resistance to CD19-CAR T-cell therapy.

Main Methods:

  • Development of the simultaneous tumor and effector profiling (STEP) approach.
  • Application of STEP to analyze patient samples from CD19-CAR T-cell therapy.

Main Results:

  • STEP successfully profiled both tumor and immune cells simultaneously.
  • Novel biological insights into resistance mechanisms were obtained.

Conclusions:

  • The STEP approach is effective for studying CAR T-cell therapy resistance.
  • Findings pave the way for developing strategies to overcome resistance in large B-cell lymphomas.

More Related Videos

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.8K
In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function08:04

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

11.8K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
1.9K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K